Singapore markets closed

Oxford Biomedica plc (OXB.L)

LSE - LSE Delayed price. Currency in GBp (0.01 GBP)
Add to watchlist
330.00-2.50 (-0.75%)
At close: 04:35PM BST
Show:
Balance sheet
Cash flow
Annual

Income statement

Currency in GBP. All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
89,539
89,539
139,989
142,797
87,728
-
Cost of revenue
49,812
49,812
70,808
60,157
41,655
-
Gross profit
39,727
39,727
69,181
82,640
46,073
-
Operating expenses
Research development
59,353
59,353
60,937
40,189
29,749
-
Selling general and administrative
25,413
25,413
28,223
15,152
11,262
-
Total operating expenses
124,691
124,691
99,350
61,707
50,936
-
Operating income or loss
-84,964
-84,964
-30,169
20,933
-4,863
-
Interest expense
11,199
11,199
8,754
888
912
-
Income before tax
-188,527
-188,527
-45,976
19,880
-6,572
-
Income tax expense
-4,365
-4,365
-817
869
-327
-
Income from continuing operations
-184,162
-184,162
-45,159
19,011
-6,245
-
Net income
-157,490
-157,490
-39,157
19,011
-6,245
-
Net income available to common shareholders
-157,490
-157,490
-39,157
19,011
-6,245
-
Basic EPS
-0.64
-
-0.41
0.23
-0.08
-0.22
Diluted EPS
-0.64
-
-0.41
0.22
-0.08
-0.22
Basic average shares
96,405
-
94,830
83,484
79,945
72,710
Diluted average shares
96,405
-
94,830
85,619
79,945
72,710